InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Forman Mark S. Officer active across 2 companies, notably Ventyx Biosciences, Inc.. Aggregated, 5 filings have been logged. History available since 15 May 2025. The latest transaction was filed on 17 November 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Forman Mark S is linked to Ventyx Biosciences, Inc. and Passage BIO, Inc., where the listed role is Chief Medical Officer for the first company and CHIEF MEDICAL OFFICER for the second. He has 5 filings in total, and in the recent sampled filings the period runs from 2024-01-03 to 2026-03-04, with buy and sell amounts of 0 EUR each and the transaction nature listed as Attribution.